<DOC>
	<DOCNO>NCT01756170</DOCNO>
	<brief_summary>This phase III study design examine low-risk ( lymph node negative ) , stage I a2-II b cervical cancer patient treat paclitaxel/cisplatin chemoradiation great toxicity similar survival rate treat radiotherapy alone .</brief_summary>
	<brief_title>Postoperative Chemoradiation v.s Radiotherapy Lymph Node Negative Cervical Cancer Patients</brief_title>
	<detailed_description>Cervical carcinoma one common gynecologic cancer worldwide . Concurrent radiotherapy cisplatin-based chemotherapy become standard treatment patient high risk factor cervical cancer . However , treatment modality patient low-risk ( lymph node negative ) still disputable . It yet know whether cisplatin-based chemoradiotherapy effective radiotherapy alone treat patient . Therefore , investigator go perform efficacy safety study postoperative concurrent paclitaxel/cisplatin chemoradiotherapy vs. radiotherapy alone lymph node negative patient early-stage cervical cancer follow radical hysterectomy .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Undertaken radical hysterectomy diagnosis invasive cervical cancer ( nonsmall cell type ) Negative lymph node At least two risk factor ( interstitial infiltration great 1/3 , vascular lymphatic involvement , cervix neoplasm large 4 cm , nerve involvement ) Eastern Cooperative Oncology Group 02 Expected life span 6 month . No distant metastasis Adequate bone marrow function ( absolute neutrophil count≥ 1,500/ul , blood platelet≥ 100,000/ul , haemoglobin≥ 10g/dl ) Adequate renal function ( serum creatinine ≤ 1.5mg/dl ) Adequate liver function ( serum bilirubin ≤ 1.5mg/dl , aspartate aminotransferase/alanine aminotransferase ≤ 3 time ( normal value ) Written inform consent Previous history chemotherapy radiation Hypersensitive reaction platinum/paclitaxel agent History cancer Concurrent systemic illness appropriate chemotherapy Active infection require antibiotic Pregnancy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>cervical cancer</keyword>
	<keyword>radiotherapy</keyword>
	<keyword>postoperative therapy</keyword>
	<keyword>chemotherapy</keyword>
</DOC>